Loading...
Loading...
In a report published Monday, Stifel analyst Steve Rubis reiterated a Buy rating on
Everyday HealthEVDY, and raised the price target from $18.00 to $22.00.
In the report, Stifel noted, “We believe Everyday Health continues to benefit from strong biopharmaceutical advertising trends. Throughout 2Q14, the interactive brand sponsorships under the Everyday Solutions section exhibited robust growth. Not only have we seen sponsorship growth but also new sponsors join the platform, as well as strong brand diversity across the interactive sponsorship links we track. In our view, these trends suggest that Everyday Health remains poised to outperform over the coming quarters. We believe their robust ROI analytics capabilities will continue to help them benefit from a strong biopharmaceutical advertising environment.”
Everyday Health closed on Friday at $18.71.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in